233 related articles for article (PubMed ID: 38113527)
1. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q
ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
3. Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure.
Chen C; Ni X; Jia S; Liang Y; Wu X; Kong D; Ding D
Adv Mater; 2019 Dec; 31(52):e1904914. PubMed ID: 31696981
[TBL] [Abstract][Full Text] [Related]
4. Combining PD-L1 blockade with immunogenic cell death induced by AIE photosensitizer to improve antitumor immunity.
Li J; Dai J; Zhuang Z; Meng Z; Hu JJ; Lou X; Xia F; Zhao Z; Tang BZ
Biomaterials; 2022 Dec; 291():121899. PubMed ID: 36343606
[TBL] [Abstract][Full Text] [Related]
5. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death.
Li W; Yang J; Luo L; Jiang M; Qin B; Yin H; Zhu C; Yuan X; Zhang J; Luo Z; Du Y; Li Q; Lou Y; Qiu Y; You J
Nat Commun; 2019 Jul; 10(1):3349. PubMed ID: 31350406
[TBL] [Abstract][Full Text] [Related]
6. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage.
Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF
Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440
[TBL] [Abstract][Full Text] [Related]
7. Rationally Designed Heptamethine Cyanine Photosensitizers that Amplify Tumor-Specific Endoplasmic Reticulum Stress and Boost Antitumor Immunity.
Huang X; Gao M; Xing H; Du Z; Wu Z; Liu J; Li T; Cao J; Yang X; Li R; Wang W; Wang J; Luo S
Small; 2022 Aug; 18(34):e2202728. PubMed ID: 35796192
[TBL] [Abstract][Full Text] [Related]
8. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.
Turubanova VD; Mishchenko TA; Balalaeva IV; Efimova I; Peskova NN; Klapshina LG; Lermontova SA; Bachert C; Krysko O; Vedunova MV; Krysko DV
Sci Rep; 2021 Mar; 11(1):7205. PubMed ID: 33785775
[TBL] [Abstract][Full Text] [Related]
9. Tailoring the Amphiphilic Structure of Zwitterionic AIE Photosensitizers to Boost Antitumor Immunity.
Zhang T; Yang X; Ou X; Lee MMS; Zhang J; Xu C; Yu X; Gong P; Lam JWY; Zhang P; Tang BZ
Adv Mater; 2023 Sep; 35(38):e2303186. PubMed ID: 37312246
[TBL] [Abstract][Full Text] [Related]
10. Rationally Integrated Precise ER-Targeted and Oxygen-Compensated Photodynamic Immunostimulant for Immunogenicity-Boosted Tumor Therapy.
Qian Y; Wang M; Xie Y; Sun Q; Gao M; Li C
Adv Healthc Mater; 2023 Dec; 12(32):e2301728. PubMed ID: 37602576
[TBL] [Abstract][Full Text] [Related]
11. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
12. ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines.
Liu X; Liu Y; Li X; Huang J; Guo X; Zhang J; Luo Z; Shi Y; Jiang M; Qin B; Du Y; Luo L; You J
ACS Nano; 2022 Jun; 16(6):9240-9253. PubMed ID: 35713245
[TBL] [Abstract][Full Text] [Related]
13. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma.
Liu Z; Zhang J; Liu H; Shen H; Meng N; Qi X; Ding K; Song J; Fu R; Ding D; Feng G
Adv Mater; 2023 Feb; 35(7):e2208692. PubMed ID: 36529696
[TBL] [Abstract][Full Text] [Related]
14. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.
Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631
[TBL] [Abstract][Full Text] [Related]
15. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV
Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy.
Feng X; Lin T; Chen D; Li Z; Yang Q; Tian H; Xiao Y; Lin M; Liang M; Guo W; Zhao P; Guo Z
Acta Biomater; 2023 Apr; 160():211-224. PubMed ID: 36792045
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy.
Deng H; Zhou Z; Yang W; Lin LS; Wang S; Niu G; Song J; Chen X
Nano Lett; 2020 Mar; 20(3):1928-1933. PubMed ID: 32073871
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Membrane-Camouflaged Aggregation-Induced Emission Nanoparticles Enhance Photodynamic-Immunotherapy to Delay Postoperative Tumor Recurrence.
Meng Z; Wang T; Hu Y; Ouyang H; Wang Q; Wu M; Zhou J; Lou X; Wang S; Dai J; Xia F
Adv Healthc Mater; 2024 Feb; 13(4):e2302156. PubMed ID: 37838834
[TBL] [Abstract][Full Text] [Related]
19. An Endoplasmic Reticulum Targeting Type I Photosensitizer for Effective Photodynamic Therapy against Hypoxic Tumor Cells.
Li S; Chen Y; Wu Y; Yao S; Yuan H; Tan Y; Qi F; He W; Guo Z
Chemistry; 2022 Dec; 28(72):e202202680. PubMed ID: 36170107
[TBL] [Abstract][Full Text] [Related]
20. Aggregation-induced emission photosensitizer/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment.
Zhu Z; Liu Q; Zhu K; Wang K; Lin L; Chen Y; Shao F; Qian R; Song Y; Gao Y; Yang B; Jiang D; Lan X; An R
Acta Biomater; 2023 Sep; 167():519-533. PubMed ID: 37328041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
